Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Findsnews2022-11-09T17:28:16+00:00November 9th, 2022|The New York Times|
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlementnews2022-11-03T21:11:11+00:00November 3rd, 2022|The New York Times|
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Casesnews2022-11-02T21:46:14+00:00November 2nd, 2022|The New York Times|
CVS, Walgreens and Walmart Must Pay $650.5 Million in Ohio Opioids Casenews2022-08-17T21:04:19+00:00August 17th, 2022|The New York Times|
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdosesnews2022-07-26T07:02:48+00:00July 26th, 2022|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|
Supreme Court Sides With Doctors Accused of Running Pill Millsnews2022-06-27T18:47:54+00:00June 27th, 2022|The New York Times|
More Americans Are Dying of Drug Overdoses Than Ever Beforenews2022-06-24T09:00:52+00:00June 24th, 2022|The New York Times|